{"url_path":"/sec/ppcb/8-k/2026-07-14/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-033173-index.html","accession_number":"0001493152-26-033173","cik":"0001517681","ticker":"PPCB","issuer_name":"Propanc Biopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-033173-index.html","primary_entity_key":"0001517681","primary_entity_name":"Propanc Biopharma, Inc."},"word_count":295,"has_tables":true,"body_markdown":"**Item 5.02.\nDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain\nOfficers.**\n\n \n\nEffective\nJuly 8, 2026, Annie Van Broekhoven retired and stepped down from the Board of Directors (the “Board”) of Propanc Biopharma,\nInc. (the “Company”) and the Company accepted her resignation. That same day, the Board filled the vacancy on the Board left\nby Ms. Van Broekhoven’s resignation and appointed Carlo Campiciano to serve on the Board until his resignation or removal.\n\n \n\nMr.\nCampiciano is a qualified accountant and member of the Institute of Public Accountants in Australia, and has extensive business\nexperience in taxation, finance operations, planning and financial strategy. Mr. Campiciano obtained a Master of Entrepreneurship and\nInnovation from Swinburne University of Technology, Graduate Diploma in Computing from Monash University Caulfield (formerly Caulfield\nInstitute of Technology) as well as a Bachelor of Business (Accounting) from RMIT University and Certificate in Corporate Governance\nfrom the Governance Institute. Mr. Campiciano also holds US GAAP certification. Mr. Campiciano has been the CFO and Company Secretary\nof MedAdvisor Limited, a company listed on the Australian Securities Exchange (ASX). Mr. Campiciano was part of the foundation team that\nlaunched MedAdvisor in 2012 and since its launch has been key in raising several rounds of capital, as well as the company’s listing\non the ASX in December 2015. As part of the executive team of MedAdvisor, Mr. Campiciano has been instrumental in the strategic\nand operational development of the business, which included seeing MedAdvisor expand its operations to be a market leader in Australia\nas well as establishing the business in the USA and Asia. Additionally, Mr. Campiciano spent twelve years lecturing in venture finance\nin the Masters of Entrepreneurship and Innovation program at the Swinburne Graduate School of Entrepreneurship."}